|
Match
|
Document |
Document Title |
|
|
7569236 |
Sustained-release microgranules containing gingko biloba extract and the process for manufacturing these
The subject of the present invention is a new stable herbal drug formulation in the form of sustained-release microgranules containing Gingko Biloba extract as well as the process for preparing it.
|
|
|
7541347 |
Minocycline oral dosage forms for the treatment of acne
Minocycline oral dosage forms containing a controlled release carrier are useful for the treatment of acne.
|
|
|
7510729 |
Combination of polyvinyl acetate with water-insoluble, acid-insoluble, or alkali-insoluble polymers used for the production of film coatings with highly controlled release and high stability
The invention relates to the combination of polyvinyl acetate and water-insoluble, acid-insoluble, or alkali-insoluble polymers used for producing film coatings for forms of administration in which...
|
|
|
7423004 |
Solid dispersion compositions
Disclosed is a water-dispersible solid composition of a sparingly water-soluble compound in a particulatable lipidic carrier, methods for the preparation and use of the same. The compositions of...
|
|
|
7390506 |
Lipophilic drug compositions
The invention is directed to biologically active lipophilic compositions comprising a biologically active covalently attached to, or encapsulated within, a lipid. Preferably, a biologically active...
|
|
|
7381227 |
Fabric laundering
Relatively low levels of polysaccharides in combination with small, deformable, water-insoluble particles of a size in the range 0.05-5 microns are capable of giving benefits in a wash liquor in...
|
|
|
7338928 |
System for releasing encapsulated active ingredients
The present invention relates to a controlled release system that can be incorporated in cosmetic, personal care, and household products to effectively encapsulate wide range of active ingredients...
|
|
|
7252840 |
Use of simple amino acids to form porous particles
Particles having a tap density of less than 0.4 g/cm 3 include a hydrophobic amino acid or salt thereof and a therapeutic, prophylactic or diagnostic agent or any combination thereof. Preferred...
|
|
|
7235260 |
Pharmaceutical compositions of a sparingly soluble glycogen phosphorylase inhibitor
Pharmaceutical compositions of a particularly effective sparingly soluble glycogen phosphorylase inhibitor are disclosed, as well as methods of making such compositions and dosage forms from such...
|
|
|
7220433 |
Compositions for parenteral administration and sustained-release of therapeutic agents
The present invention is directed to parenterally-administrable microparticles for providing sustained-release of a therapeutic agent in the body, where the microparticles include a polymeric core...
|
|
|
7176171 |
Low-viscosity opacifiers without anionic surface-active agents
An emulsifier mixture for use in a wax-based opacifier composition is comprised of: (a) an alkyl and/or alkenyl oligoglycoside; (b) a fatty acid partial glyceride and optionally (c) at least one...
|
|
|
7164010 |
Molecular magnetic protein
A highly magnetically aligned metallothionein (MT) containing manganese (Mn) and cadmium (Cd) has been synthesized. The metallotionein has a formula of Mn x Cd 7−x MT with x being in the range...
|
|
|
7163700 |
Amorphous drug beads
The present inventive subject matter relates to amorphous drug beads comprising an amorphous active drug and an organic surfactant having improved solubility, absorption and wettability...
|
|
|
7125568 |
Lipophilic drug compositions
The invention is directed to biologically active lipophilic compositions comprising a biologically active covalently attached to, or encapsulated within, a lipid. Preferably, a biologically active...
|
|
|
7101576 |
Nanoparticulate megestrol formulations
The present invention is directed to nanoparticulate compositions comprising megestrol. The megestrol particles of the composition have an effective average particle size of less than about 2000 nm.
|
|
|
7067153 |
Microcapsule powder
A process for making hydrophobicized powders of micro- and/or nanocapsules involving the steps of: (a) providing an aqueous polymer solution containing at least one active ingredient and at least...
|
|
|
7067152 |
Multi component moisture triggered controlled release system that imparts long lasting cooling sensation on the target site and/or provides high impact fragrance or flavor burst
The present invention relates to cosmetic formulations comprising a multi component controlled release system that imparts long lasting cooling sensation and/or provides high odor or flavor...
|
|
|
7067145 |
Use of arachidonic acid for enhanced culturing of fish larvae and broodstock
A method of enhancing a culturing characteristic of fish larvae, including administering to said larvae in a nutritional diet essential fatty acids including DHA and AA in a ratio effective to...
|
|
|
7060263 |
Super absorption Coenzyme Q10
An improved soft gelatin formulation and process methodology that increases single Coenzyme Q 10 molecules presented to the absorption channels of the small intestines by providing medium chain...
|
|
|
7034037 |
Compositions and medical devices utilizing bioabsorbable polymeric waxes and rapamycin
The present invention is directed to medical devices and pharmaceutical or agricultural compositions, and seeds, each containing a synthetic, bioabsorbable, biocompatible polymeric wax that is the...
|
|
|
7018657 |
Particulate composition
Nanoparticles are prepared from a colloidal system comprising a continuous phase and micelles, the micelles comprising surfactant material. A microemulsion is formed by admixing the colloidal...
|
|
|
6994873 |
Multiparticulate formulations of lithium salts for oral administration suitable for once-a-day administration
This invention refers to:
multiparticulate formulations of Lithium salts for oral administration constituted by either modified release granules or mixtures of modified and conventional...
|
|
|
6974593 |
Insoluble drug delivery
Particles of water insoluble biologically active compounds, particularly water-insoluble drugs, with an average size of 100 nm to about 300 nm, are prepared by dissolving the compound in a solution...
|
|
|
6974592 |
Encapsulated agglomeration of microcapsules and method for the preparation thereof
Microcapsules comprising an agglomeration of primary microcapsules, each individual primary microcapsule having a primary shell and the agglomeration being encapsulated by an outer shell, may be...
|
|
|
6969530 |
Microcapsules and emulsions containing low bloom gelatin and methods of making and using thereof
Described herein are microcapsules and emulsions prepared from low Bloom gelatin and methods of making and using thereof.
|
|
|
6955823 |
Process for making microcapsules involving phase inversion
A process for making microcapsules of an oil which are in dispersion in water comprises the steps of; (i) forming an initial dispersion of the oil in water in the presence of a surfactant, (ii)...
|
|
|
6953593 |
Sustained-release microencapsulated delivery system
Disclosed is a process for producing sustained-release powders that is fast, efficient, and economical. The process involves melting an animal or vegetable oil with a melting point above 110...
|
|
|
6951655 |
Pro-micelle pharmaceutical compositions
The present invention provides pro-micelle compositions comprising a pharmaceutically active agent encapsulated with a membrane of esterified C 12 -C 18 fatty acids. In the mammalian intestine,...
|
|
|
6939560 |
Pharmaceutical composition having two coating layers
The present invention provides a pharmaceutical composition which is substantially free of unpleasant tastes and orally administrable which comprises:
(a) an active medicament, (b) an inner...
|
|
|
6926938 |
Hardshell gelatin capsule reducing the static electricity and enhancing the lubrication of film
The present invention provides a process for preparing hardshell gelatin capsule reducing the static electricity and enhancing the lubrication of film having good film distribution in capsule...
|
|
|
6921541 |
Formulations and methods for providing prolonged local anesthesia
A formulation and methods for inducing sustained regional local anesthesia in a patient comprising a substrate comprising a local anesthetic and an effective amount of a biocompatible,...
|
|
|
6887494 |
Pigments and extender pigments with enhanced skin adhesion for cosmetic preparations
A composition and method for enhancing skin adhesion of cosmetics by using pigments and extender pigments for the cosmetics, which pigments and extender pigments are treated with at least one...
|
|
|
6861064 |
Encapsulation method
A novel method of encapsulating an active substance in a biodegradable polymer, which comprises: a) dissolving said biodegradable polymer in an organic solvent therefor; b 1 ) dispersing said...
|
|
|
6787150 |
Seed coating for bypassing the ruminant digestive tract
Pasture grass and legume seeds are protected with an outer coating of insoluble fatty acid salts. The coated seeds are fed to ruminants and bypass their digestive tract. When the coated seeds exit...
|
|
|
6759060 |
Synthetic particulate vectors and preparation process
A synthetic particulate vector comprising a non-liquid hydrophilic nucleus which does not have an external lipid layer grafted thereon. A method for preparing a particulate vector by encapsulating...
|
|
|
6749867 |
Delivery system for omeprazole and its salts
The present invention provides a time-release dosage form for delivering an acid-labile pharmaceutical, such as omeprazole, into the upper portion of the gastrointestinal tract downstream of the...
|
|
|
6737082 |
Pharmaceutical oral preparation of a compound having an antifungic activity, and preparation method
It comprises a compound having antifungal activity as active principle, an inert core and a coating including said active principle, and is characterized in that said inert core has a particle size...
|
|
|
RE38459 |
Emulsion stability
An injectable physiologically acceptable aqueous phase fluorocarbon emulsion, which has substantially no free fluorocarbon, has an excellent stability is prepared by a process of the invention....
|
|
|
6699506 |
Pharmaceutical composition with extended release of Milnacipran
The invention concerns a pharmaceutical composition with prolonged release, for oral administration of a single daily dose of 60 to 140 mg of Milnacipran, having a multi-particulate form containing...
|
|
|
6699501 |
Polyelectrolyte coverings on biological templates
The invention relates to a method for producing capsules provided with a polyelectrolyte covering, and to the capsules obtained using this method.
|
|
|
6696090 |
Electro-powder
A method and a process are disclosed for preparation of medical electro-powders. The electro-powder results from preparations of chemical and biological substances to form electro-powders suitable...
|
|
|
6692771 |
Emulsions as solid dosage forms for oral administration
Novel emulsion compositions which improve the rate and/or extent of absorption of drugs are disclosed. The novel emulsion compositions of the present invention include drug-containing emulsions...
|
|
|
6692769 |
Sustained-release particles
The present invention discloses sustained release particles having a mean particle size of 300 μm, or less, comprising a drug-containing core substance coated with a mixed coating of a hydrophobic...
|
|
|
6683194 |
Tocopherol derivatives
Tocopherol derivatives are provided. In one embodiment, the tocopherol derivative includes a tocopherol moiety covalently coupled to branched hydrophilic moiety. In another embodiment, the...
|
|
|
6652865 |
Method and formulation for decreasing statin metabolism
A pharmaceutical composition for oral use is disclosed. It includes, as active principle, a drug liable to undergo a strong first intestinal passage effect and a carrier which is...
|
|
|
6641844 |
Modified carrier particles for use in dry powder inhalers
The invention relates to carrier particles for use in pharmaceutical compositions for the pulmonary administration of medicaments by means of dry powder inhalers. In particular, the invention...
|
|
|
6639113 |
Production of dry powders of one or more oxygenated carotenoids
A process is described for preparing dry powders of one or more oxygenated carotenoids by a) dispersing one or more oxygenated carotenoids in an aqueous molecular dispersion or colloidal...
|
|
|
6638534 |
Preparation capable of releasing drug at target site in intestine
A preparation capable of releasing a medicinal substance at a targeted site in the intestine, wherein the preparation dose not releases medicinal substance in endogastri at all, but can quickly...
|
|
|
6623755 |
Pharmaceutical tablets
The present invention relates to novel pharmaceutical tablets useful for administering pharmaceutical active ingredients, such as bisphosphonates. These tablets have improved surface properties...
|
|
|
6569463 |
Solid carriers for improved delivery of hydrophobic active ingredients in pharmaceutical compositions
The present invention provides solid pharmaceutical compositions for improved delivery of a wide variety of pharmaceutical active ingredients contained therein or separately administered. In one...
|